SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001104659-24-086802
Filing Date
2024-08-07
Accepted
2024-08-07 17:30:18
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC TO-C tm2421037d1_sctoc.htm SC TO-C 22195
2 EXHIBIT 99.1 tm2421037d1_ex99-1.htm EX-99.1 31733
  Complete submission text file 0001104659-24-086802.txt   55601
Mailing Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709
Business Address 700 PARK OFFICES DRIVE SUITE 200 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Subject) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-90214 | Film No.: 241185179
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ROERVANGSVEJ 30 HOLBAEK G7 DK-4300
Business Address ROERVANGSVEJ 30 HOLBAEK G7 DK-4300 45 5948 5959
Pharmacosmos A/S (Filed by) CIK: 0002032940 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC TO-C